Patient Profile 1

Aged 5, female with mild-to-moderate eczema3

Reason for visit:
2-month history of localized rash with patches and scaling on the hands and fingers
Areas affected:
Hands and fingers
Medication prescribed:
STAQUISTM, twice daily
Outcome:
Experienced side effect of burning. Improvement observed over 2 weeks
Having used STAQUIS™, patient’s rash on hands and fingers improved over 2 weeks
BEFORE: DAY 1
Having used STAQUIS™, patient’s rash on hands and fingers improved over 2 weeks
AFTER: DAY 14

My daughter has had mild-to-moderate eczema since she turned 2.

I tell everyone how much we count on STAQUISTM!

Mother of the patient
Not all patients may respond to treatment with STAQUISTM. Individual results may vary. Please consult your physician for more information.

Patient Profile 2

Aged 72, female with mild-to-moderate eczema3

Reason for visit:
History of localized skin rash
Areas affected:
Lower legs
Medication prescribed:
STAQUISTM, twice daily
Outcome:
Improvement observed over 4 weeks
With STAQUIS™, patient’s skin rash in lower legs relieved over 4 weeks
BEFORE: DAY 1
With STAQUIS™, patient’s skin rash in lower legs relieved over 4 weeks
DAY 14
With STAQUIS™, patient’s skin rash in lower legs relieved over 4 weeks
AFTER: DAY 28
Not all patients may respond to treatment with STAQUISTM. Individual results may vary. Please consult your physician for more information.

Patient Profile 3

Aged 18, female with mild-to-moderate eczema3

Reason for visit:
2-month history of localized skin rash, discoloration, scaling and crusting
Areas affected:
Hands and fingers
Medication prescribed:
STAQUISTM, twice daily
Outcome:
Improvement observed over 2 weeks
After using STAQUIS™, patient’s skin rash, discoloration, scaling and crusting improved over 2 weeks
BEFORE: DAY 1
After using STAQUIS™, patient’s skin rash, discoloration, scaling and crusting improved over 2 weeks
AFTER: DAY 14
Not all patients may respond to treatment with STAQUISTM. Individual results may vary. Please consult your physician for more information.